Role of circulating free Alu DNA in endometrial cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 1, 2012, Pages 82-86

  Tanaka, Hideo ^a   Tsuda, Hiroshi ^a   Nishimura, Sadako ^b   Nomura, Hiroyuki ^a   Kataoka, Fumio ^a   Chiyoda, Tatsuyuki ^a   Tanaka, Kyoko ^a   Iguchi, Yoko ^a   Susumu, Nobuyuki ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Endometrial cancer; Screening; Serum biomarker

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA FRAGMENT; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CELL DENSITY; CELL FREE SYSTEM; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN CELL; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; RADICAL HYSTERECTOMY; SALPINGOOOPHORECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ALU ELEMENTS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DNA; EARLY DETECTION OF CANCER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84863294104     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182328c94     Document Type: Article

References (17)

1. Mandel P, Metais P. Les acides nucleiques du plasma sanguine chez I'homme. C R Seances Soc Biol Fil. 1948;142:241-243.
2. Leon SA, Green A, Yaros MJ, et al. Radioimmunoassay for nanogram quantities of DNA. J Immunol Methods. 1975;9:157-164.
3. Galeazzi M, Morozzi G, Piccini M, et al. Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmun Rev. 2003;2:50-55. (Pubitemid 37443872)
4. Stroun M, Maurice P, Vasioukhin V, et al. The origin and mechanism of circulating DNA. Ann N Y Acad Sci. 2000;906:161-168. (Pubitemid 30255476)
5. Zheng Z, Luo Y, McMaster GK. Sensitive and quantitative measurement of gene expression directly from a small amount of whole blood. Clin Chem. 2006;52:1294-1302. (Pubitemid 43956020)
6. Hwu HR, Roberts JW, Davidson EH, et al. Insertion and/or deletion of many repeated DNA sequences in human and higher ape evolution. Proc Natl Acad Sci U S A. 1986;83:3875-3879. (Pubitemid 16062385)
7. Gordian E, Ramachandran K, Reis IM, et al. Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease. Cancer Epidemiol Biomarkers Prev. 2010;19:1984-1991.
8. Kamat AA, Baldwin M, Urbauer D, et al. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer. 2010;116:1918-1925.
9. Kamat AA, Bischoff FZ, Dang D, et al. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol Ther. 2006;5:1369-1374. (Pubitemid 44772266)
10. Pathak AK, Bhutani M, Kumar S, et al. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem. 2006;52:1833-1842. (Pubitemid 44470688)
11. Zachariah RR, Schmid S, Buerki N, et al. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol. 2008;112:843-850.
12. Wu TL, Zhang D, Chia JH, et al. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta. 2002;321:77-87. (Pubitemid 34597056)
13. Ellinger J, Albers P, Perabo FG, et al. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol. 2009;182:324-329.
14. Zhang R, Shao F, Wu X, et al. Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis. Lung Cancer. 2010;69:225-231.
15. Dobrzycka B, Terlikowski SJ, Mazurek A, et al. Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer. Int J Cancer. 2010;127:612-621.
16. Chiu RW, Poon LL, Lau TK, et al. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem. 2001;47:1607-1613. (Pubitemid 32781573)
17. Lui YY, Chik KW, Chiu RW, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem. 2002;48:421-427. (Pubitemid 34174575)